Market insight in association with

First single-use duodenoscope approved by the FDA

Duodenoscopes are side-viewing endoscopes primarily designed for endoscopic retrograde cholangiopancreatography (ERCP) for visualization of the interior of the duodenum.


Traditionally used duodenoscopes include flexible non-video (fibre) duodenoscopes and flexible video duodenoscopes. Fibre duodenoscopes have a flexible insertion tube with an eyepiece for visualization. They may or may not have an add-on camera to take images of the target location. Flexible video duodenoscopes have a flexible insertion tube with video recording functionality, which uses a charge-coupled device to display magnified images on a video screen. While fibre duodenoscopes were once used most, flexible video duodenoscopes now dominate the market, with the non-video scopes mostly becoming obsolete. Currently, Olympus Corporation is the market leader for duodenoscopes, with companies, including Karl Storz, Fujifilm Holding, and Pentax having smaller market shares.


In December 2019, the FDA announced that it had approved the first fully disposable duodenoscope, manufactured by Boston Scientific. The scope, referred to as the EXALT Model D Single-Use Duodenoscope, was given the Breakthrough Device Designation, as it is the first and only single-use duodenoscope on the market approved in the US. The Breakthrough Devices Program is used to distinguish new medical devices that provide significant advancements in medicine and diagnostics. The EXALT Single-Use Duodenoscope will be safer to use since this device will not need to be reprocessed. Traditional duodenoscopes are used on multiple patients and need to be sterilized between uses. Improper sterilization can result in the spread of infection with detrimental outcomes to patients. This is especially true for duodenoscopes because they have many small parts that are difficult to clean.


GlobalData estimates the global market for duodenoscopes in 2019 to have been worth over $360m with positive growth over the next ten years. The introduction of Boston Scientific’s EXALT Single-Use Duodenoscope in 2020 is expected to act as a major disruptor to the duodenoscope market, resulting in a rapid rise of Boston Scientific’s market share. Companies that manufacture duodenoscopes should expedite research and development related to the ease of re-sterilisation so that they can remain competitive.

For more insight and data, visit the GlobalData Report Store.

Go to article: Home | The implant generation Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: In This Issue Go to article: Contents Go to article: NewsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: The Medical Industry BriefingGo to article: Timeline: the evolution of hearing aidsGo to article: Open wide: how 3D printing is reshaping dentistryGo to article: Regulating implants: how to ensure safety Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: From Grinders to Biohackers: where medical technology meets body modificationGo to article: Coat XGo to article: confinis Company Insight Go to article: confinisGo to article: Q&A: how tech can unleash preventative personalised medicine with VeritaGo to article: No filter: understanding how medicines impact dehydration Go to article: Medical tourism: how is digital tech reshaping the industry?Go to article: Triple combo: calming Alzheimer’s agitation with AI, wearables and a novel drugGo to article: Report raises doubts about influential clinical trial and heart disease guidelinesGo to article: First single-use duodenoscope approved by the FDAGo to article: Key trends of blockchain in healthcare in 2020Go to article: Epidural stimulator may help paralysed individuals regain mobilityGo to article: Debate over reuse of single-use medical devices rages onGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue